Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn J Lesser

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Supportive Oncology|June 12, 2012
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancerGlenn J Lesser, Doug Case, Nancy Stark, et al.
Future Medicinal Chemistry|August 10, 2018
Hypoxia-inducible factor 2α: a novel target in gliomasJaclyn J Renfrow, Michael H Soike, Waldemar Debinski, et al.
Pharmaceutics|April 3, 2021
Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood-Brain Barrier PermeabilityAndrei Molotkov, Patrick Carberry, Martin A Dolan, et al.
Neuro-Oncology|April 10, 2014
Influenza vaccine immunogenicity in patients with primary central nervous system malignancyRoy E Strowd, Katrina Swett, Michele Harmon, et al.
Integrative Cancer Therapies|January 20, 2017
A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck CancerMridul Datta, Edward G Shaw, Glenn J Lesser, et al.
Human Genomics|June 15, 2019
Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort studyEunkyung Lee, Cristiane Takita, Jean L Wright, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Neuro-Oncology Practice|August 7, 2019
Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancyRoy E Strowd, Gregory Russell, Fang-Chi Hsu, et al.
Plos One|January 29, 2024
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702John B Fiveash, Xiaobu Ye, David M Peerboom, et al.
Journal of Neuro-Oncology|July 23, 2014
Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgeryAndrew J Huang, Karen E Huang, Brandi R Page, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Supportive Oncology|June 12, 2012
A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancerGlenn J Lesser, Doug Case, Nancy Stark, et al.
Future Medicinal Chemistry|August 10, 2018
Hypoxia-inducible factor 2α: a novel target in gliomasJaclyn J Renfrow, Michael H Soike, Waldemar Debinski, et al.
Pharmaceutics|April 3, 2021
Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood-Brain Barrier PermeabilityAndrei Molotkov, Patrick Carberry, Martin A Dolan, et al.
Neuro-Oncology|April 10, 2014
Influenza vaccine immunogenicity in patients with primary central nervous system malignancyRoy E Strowd, Katrina Swett, Michele Harmon, et al.
Integrative Cancer Therapies|January 20, 2017
A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck CancerMridul Datta, Edward G Shaw, Glenn J Lesser, et al.
Human Genomics|June 15, 2019
Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort studyEunkyung Lee, Cristiane Takita, Jean L Wright, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Neuro-Oncology Practice|August 7, 2019
Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancyRoy E Strowd, Gregory Russell, Fang-Chi Hsu, et al.
Plos One|January 29, 2024
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702John B Fiveash, Xiaobu Ye, David M Peerboom, et al.
Journal of Neuro-Oncology|July 23, 2014
Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgeryAndrew J Huang, Karen E Huang, Brandi R Page, et al.
Pageof 13